Ceronapril

Ceronapril
Clinical data
AHFS/Drugs.com	Monograph
ATC code	C09AA09 (WHO) ;
Identifiers
	IUPAC name 1-[(2S)-6-Amino-2-hydroxyhexanoyl]-L-proline, hydrogen (4-phenyl-butyl)phosphonate;
CAS Number	111223-26-8;
PubChem CID	189729;
ChemSpider	164789;
UNII	X3MM60SOVP;
KEGG	D03440;
CompTox Dashboard (EPA)	DTXSID80891418 ;
Chemical and physical data
Formula	C30H46NO7P
Molar mass	563.672 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES C1C[C@H](N(C1)C(=O)[C@H](CCCCN)OP(=O)(CCCCC2=CC=CC=C2)O)C(=O)O;
	InChI InChI=1S/C30H46NO7P/c1-4-28(33)37-30(22(2)3)38-39(36,18-12-11-15-23-13-7-5-8-14-23)21-27(32)31-20-25(19-26(31)29(34)35)24-16-9-6-10-17-24/h5,7-8,13-14,22,24-26,30H,4,6,9-12,15-21H2,1-3H3,(H,34,35)/t25-,26+,30?,39-/m1/s1 ; Key:BIDNLKIUORFRQP-YYTCENNOSA-N ;

Ceronapril (INN,^[1] proposed trade names Ceranapril, Novopril) is a phosphonate ACE inhibitor^[2] that was never marketed.^{[citation needed]}

Quick facts Clinical data, AHFS/Drugs.com ...

[1]

[2]

Ceronapril

References

Wikiwand - on